This is especially true when patients follow the dosing and monitoring schedule recommended in a medical setting
Every order confirms it
Whilst not always mentioned in the list of common side effects, fatigue from GLP-1 injections is a real and frustrating experience for many people, especially during the early weeks of treatment
Some healthcare providers may still prescribe these lower doses off-label for weight loss, though the results are typically more modest than with the Saxenda-strength 3 mg dose
100% achieved 5% Weight loss was dose-dependent: 4mg (-17.1%), 8mg (-22.8%), 12mg (-24.2%) at 48 weeks Results appeared early (visible by week 4) and continued throughout the 48-week trial Beyond weight: significant improvements in blood pressure, lipids, liver fat, and glycemic control Investigational Drug: Retatrutide is not FDA-approved
The Cleveland Clinic notes that long-term inflammation can contribute to serious chronic conditions when it never fully switches off